Abstract
Nanocomposites composed of highly biocompatible and safe alginate and iron oxide nanoparticles have been employed to encapsulate doxorubicine for brain tumor therapy. The antitumor activity of nanocomposites was demonstrated using in vitro and in vivo tests. The results significantly indicated that the nanocomposites had great safety and potential for brain tumor therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 90061-90064 |
| Number of pages | 4 |
| Journal | RSC Advances |
| Volume | 5 |
| Issue number | 109 |
| DOIs | |
| State | Published - 15 10 2015 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© The Royal Society of Chemistry.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'In vitro and in vivo applications of alginate/iron oxide nanocomposites for theranostic molecular imaging in a brain tumor model'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver